The future of medicine is being redefined by artificial intelligence. From digital twins and precision medicine to AI-driven medical imaging and large language models, cutting-edge technologies are transforming the way we diagnose, treat, and prevent disease.
14 July 2025
Sleep disturbances in breast cancer patients undergoing neoadjuvant chemotherapy – designed to shrink the tumours prior to surgery – are one of the common side effects of these treatments, which can not only exacerbate other side effects, but also impact prognosis. One of the possible, non-pharmacological strategies to mitigate these disturbances is thought to be physical exercise.
09 July 2025
Following Episode 5 - Part 1, where we explored the hidden world of the hypothalamus and the “love hormone” oxytocin, this second part of Hedi’s conversation with neuroendocrinologist Gareth Leng takes us even deeper.
17 June 2025
The results of the most recent European Research Council (ERC) Advanced Grants have been announced today (June 17th). In Portugal, the ERC selected two new projects in the area of life sciences, which in total will receive 5M€.
The ERC funding, worth in total €721M, will go to 281 leading researchers across Europe. In the case of life sciences, 732 proposals were submitted and 83 were selected for funding, which represents a success rate of approximately 11%.
11 June 2025
From philosophical zombies and the purpose of dreaming, to measuring consciousness like temperature and why brains aren’t computers, Seth unpacks the idea that our experience of reality – and of ourselves – is a kind of waking dream, a “controlled hallucination”, shaped by prediction, perception, and the body’s primal drive to stay alive.
His theory of what it means to ‘be you’ challenges how we understand perception – and turns what you thought you knew about yourself on its head.
05 June 2025
Following intro sessions that happened at schools back in February, nearly 200 8th-grade students from Escola do Alto do Lumiar (Lisboa) and Escola Dr. Azevedo Neves (Amadora) took part in a series of hands-on/minds-on experiments at both the GIMM Foundation and Champalimaud Foundation (CF) in March.